SPY330.30+3.33 1.02%
DIA272.81+1.37 0.50%
IXIC10,963.64+184.84 1.71%

CTI BioPharma Q1 EPS $(0.200) Down From $(0.190) YoY

CTI BioPharma (NASDAQ:CTIC) reported quarterly losses of $(0.200) per share. This is a 5.26 percent decrease over losses of $(0.190) per share from the same period last year.

Benzinga · 05/07/2020 20:57

CTI BioPharma (NASDAQ:CTIC) reported quarterly losses of $(0.200) per share. This is a 5.26 percent decrease over losses of $(0.190) per share from the same period last year.